Feature | HRS | May 15, 2019 | Dave Fornell, Editor

Heart Rhythm Society 2019 Late-Breaking Clinical Trials

HRS late-breaker studies will highlight the biggest news in electrophysiology

HRS 2019 late breaking trials, late breaking presentations for the biggest news in electrophysiology (EP). #HRS #HRS2019 #HRS19

May 15, 2019 — The Heart Rhythm Society (HRS) had 21 late-breaking study presentations at the 2019 Heart Rhythm Scientific Sessions. Here is a completed list of the studies presented with links to more information. This includes the latest in clinical research, techniques and technologies in cardiac electrophysiology (EP). For more details on HRS 2019, visit www.hrssessions.org.

 

Late Breaking Clinical Trials Session I
Thursday, May 9, 8 – 9:30 a.m.
   • Transcutaneous Electrical Vagus Nerve Stimulation To Suppress Atrial Fibrillation (TREAT AF): A Randomized Clinical Trial 

   • Prospective Randomized Comparison Of Rotor Ablation vs. Conventional Ablation For Treatment Of Persistent Atrial Fibrillation - The REAFFIRM Trial 

   • Evaluate Renal Artery Denervation In Addition to Catheter Ablation To Eliminate Atrial Fibillation (ERADICATE-AF) Trial  

   • Baroreflex Activation Therapy In Patients With Heart Failure With A Reduced Ejection Fraction  

   • His Corrective Pacing Or Bi-ventricular Pacing For Cardiac Resynchronization In Heart Failure: A Randomized Pilot Trial (HIS SYNC)

 

Late Breaking Clinical Trials Session II: New Data for Device Therapies
Friday, May 10, 1:30 – 3 p.m.
   • Update From The Prevention Of Arrhythmia Device Infection Trial (PADIT); Development Of The PADIT Infection Risk Score 

   • Decline In Ventricular Arrhythmia Events And Mortality In The Multicenter Automatic Defibrillator Implantation Trials  

   • After RAFT: Long Term Outcomes Of Cardiac Resynchronization Therapy  

   • Cardiac Resynchronization Therapy In Chemotherapy-induced Cardiomyopathy: Results Of The Multicenter Automatic Defibrillator Implantation Trial - Chemotherapy-induced Cardiomyopathy (MADIT-CHIC) Study

   • Understanding Outcomes With The S-ICD In Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Study: High Conversion Efficacy And Low Adverse Event Rate During The First 30 Days 

 

 
Late Breaking Clinical Trials Session III: Late-Breaking Science
Friday, May 10, 4:30 – 6 p.m.
   • Prospective Evaluation Of Feasibility, Electrophysiological And Echocardiographic Characteristics Of Left Bundle Branch Area Pacing 

   • Is Nonselective His Bundle Pacing Good Enough? Long-term Outcomes From The Geisinger-Rush HBP Registry

   • Preventive Ablation Of Ventricular Tachycardia In Patients With Myocardial Infarction: The BERLIN-VT Trial

   • Five-year Outcomes In Cardiac Surgery Patients With Atrial Fibrillation Undergoing Concomitant Surgical Ablation Versus No Ablation. The Long-term Follow-up of the Prague-12 Study  

   • Real-time Electrogram Analysis For Drivers Of Atrial Fibrillation (Radar): A Multi-center, FDA-IDE, Clinical Trial Of Persistent AF

   • Pulsed Field Ablation For Pulmonary Vein Isolation: Lesion Durability And Chronic Safety  

 

Late Breaking Clinical Trials Session IV: Innovations
Saturday, May 11, 10:30 a.m. - Noon 
   • First-in-human Chronic Implant Experience Of The Medtronic Substernal Extravascular Implantable Cardioverter Defibrillator

   • DIGITAL-AF II: Results From A Real-life Digital Atrial Fibrillation Screening Using Smartphones And Outcome Registry In The General Population

   • Non-invasive Localization Of Cardiac Arrhythmias Using Electromechanical Wave Ultrasound Imaging

   • A Novel Percutaneous Carotid Coil Filter For Stroke Prevention In Atrial Fibrillation: Outcomes Of The First-in-human CAPTURE Trial

   • Bipolar Catheter Ablation For The Treatment Of Refractory Scar-related Ventricular Tachycardia: A Multicenter, Prospective FDA IDE Study

 

 

Other HRS 2019 News:

Survey Shows Big Need for Patient Education on Their Implantable Electrophysiology Devices

Airport Security Body Scanners Do Not Interfere With Pacemakers, ICDs 

Studies Find Race and Gender Disparities in Implantable Heart Devices

HRS Releases New Expert Consensus Statement on Arrhythmogenic Cardiomyopathy

 

New Global Consensus Statement Addresses Catheter Ablation of Ventricular Arrhythmias

VIDEO: Use of an Antibacterial Envelope to Reduce Infections for Pacemakers, ICDs — Interview with Khaldoun Tarakji, M.D.

VIDEO: Key Trends in Electrophysiology — Apple Watch to Detect AF and the CABANA Trial — Interview with Christine Albert, M.D.,

Find links to other Heart Rhythm Scientific Sessions news

 

 

Industry News at HRS 2019:

Philips and Medtronic Collaborate on Image-guided Atrial Fibrillation Treatment

Abbott Launches Next-generation Confirm RX Implantable Cardiac Monitor

FDA Approves Attain Stability Quad MRI SureScan Lead from Medtronic

Biosense Webster Launches Cartonet Analytics Software for Electrophysiology

 

Murj Launches Murj 2.0 Implantable Cardiac Device Management Software

Acutus Medical Receives FDA Clearance for Second-generation AcQMap Platform

CardioFocus Announces European CE Mark Approval Of HeartLight X3 System

Biocardia Receives FDA Clearance for Avance Steerable Introducer Family

 

Spacelabs Debuts Sentinel 11 Cardiology Information Management System

Stereotaxis Announces Next-generation Robotic Magnetic Navigation and Imaging Systems

Preventice Solutions Presents Real-World Performance Data on BodyGuardian Remote Monitoring System With AI

CardioFocus Announces Results From HeartLight X3 Ablation System Pivotal Study

 


Related Content

News | Atrial Fibrillation

Oct. 18, 2024 — The Heart Rhythm Society (HRS) Board of Trustees unanimously approved the formation of Heart Rhythm ...

Home October 21, 2024
Home
News | Atrial Fibrillation

Sept. 11, 2024 — In the first national estimate in two decades, researchers at the University of California-San ...

Home September 11, 2024
Home
News | Atrial Fibrillation

July 24, 2024 — Volta Medical, a health technology company developing artificial intelligence (AI) solutions to assist ...

Home July 24, 2024
Home
News | Atrial Fibrillation

July 8, 2024 — Pulsed field ablation (PFA) is safe for treating patients with common types of atrial fibrillation (AF) ...

Home July 08, 2024
Home
News | Atrial Fibrillation

June 12, 2024 — A team of Ochsner Health cardiologists recently published an article in the Journal of the American ...

Home June 12, 2024
Home
News | Atrial Fibrillation

April 18, 2024 — New evidence-based research calls into question the conventional three-month blanking period ...

Home April 18, 2024
Home
News | Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
Home
News | Atrial Fibrillation

February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & ...

Home February 27, 2024
Home
News | Atrial Fibrillation

February 6, 2024 — Cortex announced the initiation of its RESOLVE-AF trial (NCT05883631), a study formally launched in ...

Home February 06, 2024
Home
News | Atrial Fibrillation

February 2, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home February 02, 2024
Home
Subscribe Now